John W Smither
Chief Financial Officer; Director · 4 filings · Latest: Sep 4, 2026
GENELUX Corp
MBX Biosciences, Inc.
NewAmsterdam Pharma Co N.V.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
NAMS | John W Smither | Director | Sep 4, 2026 | Sale | $25.32 | 1,600 | $40.5K | 8,760 | |
GNLX | John W Smither | Director | Jul 1, 2026 | Sale | $2.91 | 12,000 | $34.9K | 91,403 | |
GNLX | JOHN SMITHER | — | Jul 1, 2026 | Proposed Sale | $2.91 | 12,000 | $34.9K | — | |